|
|
|
|
|
07.07.25 - 22:09
|
KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer (Business Wire)
|
|
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced the appointment of Adam Kalbermatten as Chief Commercial Officer, effective July 28, 2025.
Adam brings over two decades of commercial leadership experience in the medical device and pharmaceutical industries, with a proven track record of scaling businesses, building high-performing teams, and delivering customer-focused innovation. As Chief Commercial Officer, he will oversee all aspects of KORU Medical's global commercial strategy—including marketing, sales, market access, and pharmaceutical customer engagement.
Adam joins KORU Medical from Becton Dickinson (BD), where he most recently served as Vice President and General Manager, Advanced Drug D...
|
|
|
05.06.25 - 23:42
|
XETR: DIVIDEND/INTEREST INFORMATION - 09.06.2025 - BOX (XETRA)
|
|
Das Instrument BOX US0758871091 BECTON, DICKINSON DL 1 EQUITY wird cum Dividende/Zinsen gehandelt am 06.06.2025 und ex Dividende/Zinsen am 09.06.2025
The instrument BOX US0758871091 BECTON, DICKINSON DL 1 EQUITY has its pre-dividend/interest day on 06.06.2025 and its ex-dividend/interest day on 09.06.2025...
|
|
|
|
|
|
|
|
|
03.05.25 - 00:06
|
Becton Dickinson Vitals Drop: Analysts Have Been Wrong On This Med Tech Stock For Years (Benzinga)
|
|
Becton Dickinson receives multiple downgrades as analysts cite weakening organic growth and trimmed price targets following a Q2 update.
Latest Ratings for BDX
DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsOverweight Feb 2022SVB LeerinkMaintainsMarket Perform Jan 2022Morgan StanleyMaintainsOverweight
View More Analyst Ratings for BDX
View the Latest Analyst Ratings
read more...
|
|
|
|
|
|
|